UEG's educational platform for gastroenterology education bringing recordings, courses, guidelines, and more together in one place.
Most popular content
Rate for better recommendations!
Your feedback helps us show you more of what you like and less of what you dislike!
Log in to access this content.
Free for all myUEG account holders. Your access level is set automatically based on your occupation. Medical professionals get full access to all content. If you are a non-medical user, you can only access UEG Week content from congresses you attended.
Not sure what you can access? Learn more about account types.
H. pylori: History of a breakthrough
1 Hopital Pellegrin, Laboratoire de Bacteriologie, Bordeaux, France
Event
Published
Log in to access this content.
Free for all myUEG account holders. Your access level is set automatically based on your occupation. Medical professionals get full access to all content. If you are a non-medical user, you can only access UEG Week content from congresses you attended.
Not sure what you can access? Learn more about account types.
Total neoadjuvant treatment: The way forward?
1 Amsterdam UMC, Amsterdam, Netherlands
Event
Citation
Published
Log in to access this content.
Free for all myUEG account holders. Your access level is set automatically based on your occupation. Medical professionals get full access to all content. If you are a non-medical user, you can only access UEG Week content from congresses you attended.
Not sure what you can access? Learn more about account types.
When to follow up after discharge?
1 University Hospital of Santiago. Health Research Institute of Santiago de Compostela (IDIS), Santiago De Compostela, Spain
Event
Session
Published
Log in to access this content.
Free for all myUEG account holders. Your access level is set automatically based on your occupation. Medical professionals get full access to all content. If you are a non-medical user, you can only access UEG Week content from congresses you attended.
Not sure what you can access? Learn more about account types.
Surveillance: Will we still need Seattle protocol in 2030?
1 University of Kansas School of Medicine Dept. of Gastroenterology, Leawood, United States
Event
Published
Log in to access this content.
Free for all myUEG account holders. Your access level is set automatically based on your occupation. Medical professionals get full access to all content. If you are a non-medical user, you can only access UEG Week content from congresses you attended.
Not sure what you can access? Learn more about account types.
MIR-21-5P DRIVES NASH-ASSOCIATED HEPATOCARCINOGENESIS
Pedro M. Rodrigues 1, Marta Bento Afonso 2, André Lopes Simão 2, Tawhidul Islam 2, Maria Manuela Gaspar 2, Colm J. O’Rourke 3, Monika Lewinska 3, Jesper B. Andersen 3, Enara Arretxe 4, Cristina Alonso 4, Álvaro Santos-Laso 5, Laura Izquierdo-Sanchez 6, Raúl Jimenez-Agüero 5, Emma Eizaguirre 5, Luis Bujanda 7, Maria J. Pareja 8, Carina Prip-Buus 9, Jesús M. Bañales 10, Cecília Maria Pereira Rodrigues 2, Rui Castro 2
1 Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Lisbon, Portugal|||Donostia University Hospital, University of the Basque Country (UPV/EHU), San Sebastian, Spain|||Centre for the Study of Liver and Gastrointes
2 Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Lisbon, Portugal
3 Biotech Research and Innovation Centre, Department of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
4 OWL Metabolomics, Derio, Spain
5 Donostia University Hospital, University of the Basque Country (UPV/EHU), San Sebastian, Spain
6 Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Lisbon, Portugal|||Donostia University Hospital, University of the Basque Country (UPV/EHU), San Sebastian, Spain
7 Donostia University Hospital, University of the Basque Country (UPV/EHU), San Sebastian, Spain|||Centre for the Study of Liver and Gastrointestinal Diseases (CIBERehd), Carlos III National Institute of Health, Madrid, Spain
8 Hospital Juan Ramón Jiménez, Huelva, Spain
9 Université Paris Descartes UMR-S 1016, Institut Cochin, Paris, France
10 Donostia University Hospital, University of the Basque Country (UPV/EHU), San Sebastian, Spain|||Centre for the Study of Liver and Gastrointestinal Diseases (CIBERehd), Carlos III National Institute of Health, Madrid, Spain|||IKERBASQUE, Basque Foundation
Event
Submission format
Session
Citation
Published
Log in to access this content.
Free for all myUEG account holders. Your access level is set automatically based on your occupation. Medical professionals get full access to all content. If you are a non-medical user, you can only access UEG Week content from congresses you attended.
Not sure what you can access? Learn more about account types.
Q&A A voyage to the future: New and evolving treatments for neurologic dysphagia
1 Universitätklinikum Münster, UK Münster, Germany
2 University Hospital Frankfurt, Frankfurt, Germany
Event
Published
Log in to access this content.
Free for all myUEG account holders. Your access level is set automatically based on your occupation. Medical professionals get full access to all content. If you are a non-medical user, you can only access UEG Week content from congresses you attended.
Not sure what you can access? Learn more about account types.
Who did it? Catching the culprit of overt mid-gut bleeding in young patients
1 Sapienza University of Rome, Rome, Italy